Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Inflammation-metabolism-fibrosis axis: mechanisms and therapeutic strategies targeting the chronicity of pelvic inflammatory disease.

PMID: 41915995 · 2026

JournalInternational immunopharmacology
Year2026
PMID41915995

Abstract

Pelvic inflammatory disease (PID) is a common infectious disease in gynecology; it can easily develop into chronic inflammation and tissue fibrosis. These conditions severely affect patients' reproductive health and quality of life. In recent years, studies have found that the inflammatory response, metabolic reprogramming, and fibrotic process interact through complex molecular mechanisms, forming an inflammation-metabolism-fibrosis axis. This axis has become a core driving factor in the chroni

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.